I-MVAC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-MVAC, covering 2021-03-09 to 2021-03-09. Get the full timeline:
Most recent: Clinical Trial Update: I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations [Phase 3]